Factors related to the improvement of the right ventricular function in patients with pulmonary embolism at short-term follow-up

Authors

  • V.Y. Tseluyko V.N. Karazin Kharkiv National University, Kharkiv, Ukraine
  • L.M. Yakovleva V.N. Karazin Kharkiv National University, Kharkiv, Ukraine
  • S.M. Sukhova MNPE “City Clinical Hospital 8” of KhCC, Kharkiv, Ukraine
  • O.V. Radchenko V.N. Karazin Kharkiv National University, Kharkiv, Ukraine

DOI:

https://doi.org/10.22141/2224-0586.18.1.2022.1457

Keywords:

pulmonary embolism, arginine, short-term prognosis, anticoagulant therapy

Abstract

Background. The purpose was to study the possible influence of Tivorel on the improvement of the right ventricular (RV) function in patients with acute pulmonary embolism (PE). Materials and methods. The study was conducted between September 1, 2019 and December 31, 2020 at the premises of the Municipal Non-Profit Enterprise “City Clinical Hospital 8” of Kharkiv City Council. The analysis included 59 patients with RV dysfunction and PE, their average age was 66.34 ± 13.48 years. Twenty-nine (49.2 %) patients were at high risk and 30 (50.8 %) at moderate-to-high risk. All individuals with PE were treated with anticoagulants according to 2019 European Society of Cardiology guidelines. Patients were divided into 2 groups using the envelope method. Group 1 (29 people) were prescribed Tivorel (42 mg of arginine hydrochloride and 20 mg of levocarnitine) manufactured by Yuria-Pharm company — 100 ml intravenously during the first five days of hospital stay, in addition to the standard therapy. Group 2 (30 patients) received the standard PE treatment. Results. According to the cardiac ultrasound results, patients with PE had an improvement of right ventricular function parameters: a significant decrease in right atrial size and volume index, RV size and mean pulmonary artery pressure (р < 0.05). By the end of the observation period, the number of patients in group I whose RV size became < 3.0 cm was 23 (79.3 %) that was significantly higher than in group II — 17 (56.7 %) people, p = 0.01. Conclusions. 43.3 % of patients at high and moderate-to-high risk of PE have ultrasonic signs of RV dysfunction after 14–21 days of standard anticoagulation therapy. According to the multivariate regression logistic analysis results, independent factors related to the normalization of RV function in patients with high and moderate-to-high risk of PE after 14–21 days are: mean pulmonary artery pressure, right atrial size and prescription of Tivorel infusions in addition to the standard therapy (p < 0.05).

Downloads

Download data is not yet available.

References

Cohen AT, Agnelli G, Anderson FA, et al; VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007 Oct;98(4):756-64.

Benjamin EJ, Muntner P, Alonso A, et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659.

Cho JH, Kutti Sridharan G, Kim SH, et al. Right ventricular dysfunction as an echocardiographic prognostic factor in hemodynamically stable patients with acute pulmonary embolism: a meta-analysis. BMC Cardiovasc Disord. 2014 May 6;14:64. doi: 10.1186/1471-2261-14-64.

Burrowes KS, Clark AR, Tawhai MH. Blood flow redistribution and ventilation-perfusion mismatch during embolic pulmonary arterial occlusion. Pulm Circ. 2011 Jul-Sep;1(3):365-76. doi: 10.4103/2045-8932.87302.

Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):370-2. doi: 10.1161/ATVBAHA.108.162545.

Kempny A, McCabe C, Dimopoulos K, et al. Incidence, mortality and bleeding rates associated with pulmonary embolism in England between 1997 and 2015. Int J Cardiol. 2019 Feb 15;277:229-234. doi: 10.1016/j.ijcard.2018.10.001.

Potočnjak I, Radulović B, Degoricija V, et al. Serum concentrations of asymmetric and symmetric dimethylarginine are associated with mortality in acute heart failure patients. Int J Cardiol. 2018 Jun 15;261:109-113. doi: 10.1016/j.ijcard.2018.03.037.

Klinger JR, Kadowitz PJ. The Nitric Oxide Pathway in Pulmonary Vascular Disease. Am J Cardiol. 2017 Oct 15;120(8S):S71-S79. doi: 10.1016/j.amjcard.2017.06.012.

Kiran GR, Chandrasekhar P, Ali SM. Association between 2D echocardiographic right atrial volume to left atrial volume (RAV/LAV) ratio and in-hospital prognosis in thrombolysed acute pulmonary thromboembolism patients. Indian Heart J. 2020 Nov-Dec;72(6):610-613. doi: 10.1016/j.ihj.2020.09.008.

Jiménez D, Bikdeli B, Barrios D, et al; RIETE investigators. Epidemiology, patterns of care and mortality for patients with hemodynamically unstable acute symptomatic pulmonary embolism. Int J Cardiol. 2018 Oct 15;269:327-333. doi: 10.1016/j.ijcard.2018.07.059.

Konstantinides SV, Meyer G, Becattini C, et al; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020 Jan 21;41(4):543-603. doi: 10.1093/eurheartj/ehz405.

Zhao G, Zhang H, Wang Y, Gao X, Liu H, Liu W. Effects of levocarnitine on cardiac function, urinary albumin, hs-CRP, BNP, and troponin in patients with coronary heart disease and heart failure. Hellenic J Cardiol. 2020 Mar-Apr;61(2):99-102. doi: 10.1016/j.hjc.2018.08.006.

Laporte S, Mismetti P, Décousus H, et al; RIETE Investigators. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation. 2008 Apr 1;117(13):1711-6. doi: 10.1161/CIRCULATIONAHA.107.726232.

Atzler D, Cracowski JL, Cordts K, Böger RH, Humbert M, Schwedhelm E. Homoarginine predicts mortality in treatment-naive patients with pulmonary arterial hypertension. Int J Cardiol. 2016 Aug 15;217:12-5. doi: 10.1016/j.ijcard.2016.04.161.

Rodionov RN, Begmatov H, Jarzebska N, et al. Homoarginine Supplementation Prevents Left Ventricular Dilatation and Preserves Systolic Function in a Model of Coronary Artery Disease. J Am Heart Assoc. 2019 Jul 16;8(14):e012486. doi: 10.1161/JAHA.119.012486.

Sandqvist A, Schneede J, Kylhammar D, et al. Plasma L-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction. Heart Vessels. 2018 Mar;33(3):255-263. doi: 10.1007/s00380-017-1055-7.

Published

2022-03-26

How to Cite

Tseluyko, V., Yakovleva, L., Sukhova, S., & Radchenko, O. (2022). Factors related to the improvement of the right ventricular function in patients with pulmonary embolism at short-term follow-up. EMERGENCY MEDICINE, 18(1), 42–47. https://doi.org/10.22141/2224-0586.18.1.2022.1457

Issue

Section

Original Researches

Most read articles by the same author(s)

1 2 > >>